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3. TGA After thermal treatment, residue analysis and proposed formulas are estimated to be the following (Note that the drug-loading content is also described by the encapsulation efficiency (EE), where EE(%) = · 100; Dt is the initial amount of drug present in the starting impregnation solution and Dl is the amount of loaded drug).
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Calculations of drug occupancy volumes.
The volume occupied by one drug molecule inside the MOF was estimated by taking into account the variation of MOF pore volume after the drug encapsulation, and the total amount of loaded drug. The drug occupancy volume has been described as:
where is the pore volume after (1) and before (2) drug encapsulation (A 3 ·g -1 ), is the molecular weight of the dried MOF after (1) and before (2) drug encapsulation, is Avogadro constant, and n is the total amount of loaded drug (mol·mol -1 ).
S10 Figure S9 . FTIR spectra of the desolvated MIL-100, UiO-66 and MIL-127 matrixes, and their corresponding aspirin (bottom) (MIL-100@AAS, UiO-66@AAS, and MIL-127@AAS) and ibuprofen (top) (MIL-100@IBU, UiO-66@IBU, and MIL-127@IBU) loaded materials. The spectra of free aspirin and ibuprofen have been included for comparison. Table S2 . CO stretching band of the FTIR spectra of the pure drugs (AAS and IBU) and the loaded matrixes MIL-100@AAS, MIL-100@IBU, UiO-66@AAS, UiO-66@IBU, MIL-127@AAS, and MIL-127@IBU. Figure S14 . TGA for pristine MIL-100, UiO-66 and MIL-127 matrixes, their corresponding drug loaded solids (MOF@drug), and the final materials obtained after the delivery process (MOF@drug_del). 1D channel system (~ 6 Å) and cages of ~ 10 Å, accessible through apertures of ~ 3 Å.
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